Delivery Order SPE2DB22D2206-SPE2DB25FFU38

Award Date 2/24/25
Potential Completion Date 3/17/25
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of TIVDAK 40 MG VIALS, a pharmaceutical product, to support military healthcare programs. The $13,083.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $11,956.29, is for the supply of TIVDAK 40 MG VIALS, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 24, 2024. There is no set-aside designation for this award. AmerisourceBergen Drug Corp's Corporate Office...
This federal contract award (SPE2DB22D3016|SPE2DB25FADS5) was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,956.29 firm fixed-price delivery order is for the supply of TIVDAK 40 MG VIALS medical product. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product TIVDAK 40 MG VIALS to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 22, 2024 and a ceiling value of $23,912.58. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $1,526.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TDVAX VIAL 0.5ML medical supplies, with an ultimate completion date of September 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $12,482.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables the government to efficiently procure a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,926.36 firm fixed price delivery order contract is for the supply of "TALVEY 40 MG/ML VIALML" medical products. The contract has an ultimate completion date of March 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $9,617.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, valued at $25,679.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award, valued at $30,442.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFU38
    Delivery Order

This federal contract award, valued at $26,167.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TIVDAK 40 MG VIALS, a medical product, with a completion date of March 17, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the requested medical product to the designated place of performance in Conshohocken, Pennsylvania.

Generated 6/1/25, 2:57 AM